CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
57
BAC Quote, Financials, Valuation and Earnings
Last price:
$40.92
Seasonality move
:
1.66%
Day range:
$40.86 - $41.34
52-week range:
$33.07 - $48.08
Dividend yield:
2.49%
P/E ratio:
12.18x
P/S ratio:
3.11x
P/B ratio:
1.12x
Volume:
28.8M
Avg. volume:
55.1M
1-year change:
8.17%
Market cap:
$308.3B
Revenue:
$101.9B
EPS (TTM):
$3.36
Analysts' Opinion
-
Consensus RatingBank of America has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $48.57, Bank of America has an estimated upside of 18.66% from its current price of $40.93.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $42.00 representing -2.61% downside risk from its current price of $40.93.
Fair Value
-
According to the consensus of 16 analysts, Bank of America has 18.66% upside to fair value with a price target of $48.57 per share.
BAC vs. S&P 500
-
Over the past 5 trading days, Bank of America has overperformed the S&P 500 by 3.64% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Bank of America does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bank of America has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Bank of America reported revenues of $27.4B.
Earnings Growth
-
Bank of America has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Bank of America reported earnings per share of $0.90.
Enterprise value:
17.3B
EV / Invested capital:
0.03x
Price / LTM sales:
3.11x
EV / EBIT:
0.15x
EV / Revenue:
0.17x
PEG ratio (5yr expected):
0.75x
EV / Free cash flow:
3.80x
Price / Operating cash flow:
70.80x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.85%
Net Income Margin (TTM):
26.93%
Return On Equity:
9.44%
Return On Invested Capital:
4.42%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $98B | $98.1B | $103.4B | $25.8B | $27.4B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $3.33 | $2.89 | $3.36 | $0.76 | $0.90 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $992.3B | $1T | $830.3B | $1.1T | $1.1T | |
| Total Assets | $3T | $3.2T | $3.2T | $3.3T | $3.3T | |
| Current Liabilities | $221.2B | $239.5B | $370.9B | $368.6B | $417.5B | |
| Total Liabilities | $2.7T | $3T | $2.9T | $3T | $3.1T | |
| Total Equity | $274B | $266.6B | $280.2B | $293.6B | $295.6B | |
| Total Debt | $272.9B | $303.5B | $340.4B | $335.2B | $345.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $27.8B | $40.7B | $4.6B | -$15.5B | -$2.2B | |
| Cash From Investing | $96.7B | -$137.6B | -$108.4B | -$71.3B | -$89B | |
| Cash From Financing | -$20.8B | $35.9B | $64.5B | $68.7B | $72.8B | |
| Free Cash Flow | $27.8B | $40.7B | $4.6B | -$15.5B | -$2.2B | |
BAC
Sector
Market Cap
$308.3B
$597.2M
Price % of 52-Week High
85.13%
84.88%
Dividend Yield
2.49%
2.02%
Shareholder Yield
6.52%
3.99%
1-Year Price Total Return
8.17%
7.66%
Beta (5-Year)
1.272
0.589
Dividend yield:
2.49%
Annualized payout:
$1.00
Payout ratio:
34.24%
Growth streak:
11 years
Technicals
8-day SMA
Buy
Level
$40.47
200-day SMA
Sell
Level
$42.37
Bollinger Bands (100)
Sell
Level
39.65 - 46.47
Chaikin Money Flow
Buy
Level
2.1B
20-day SMA
Buy
Level
$38.77
Relative Strength Index (RSI14)
Buy
Level
58.13
ADX Line
Buy
Level
15.83
Williams %R
Sell
Level
-11.2112
50-day SMA
Buy
Level
$40.35
MACD (12, 26)
Buy
Level
0.29
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
10B
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.5795)
Sell
CA Score
(Annual)
Level (-2.1629)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-0.4839)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bank of America is one of the largest financial institutions in the United States, with more than $3.2 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.
Stock Forecast FAQ
In the current month, BAC has received 14 Buy ratings 2 Hold ratings, and 0 Sell ratings. The BAC average analyst price target in the past 3 months is $48.57.
-
Where Will Bank of America Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bank of America share price will rise to $48.57 per share over the next 12 months.
-
What Do Analysts Say About Bank of America?
Analysts are divided on their view about Bank of America share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bank of America is a Sell and believe this share price will drop from its current level to $42.00.
-
What Is Bank of America's Price Target?
The price target for Bank of America over the next 1-year time period is forecast to be $48.57 according to 16 Wall Street analysts, 14 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is BAC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bank of America is a Buy. 14 of 16 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BAC?
You can purchase shares of Bank of America via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bank of America shares.
-
What Is The Bank of America Share Price Today?
Bank of America was last trading at $40.92 per share. This represents the most recent stock quote for Bank of America. Yesterday, Bank of America closed at $40.93 per share.
-
How To Buy Bank of America Stock Online?
In order to purchase Bank of America stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
76
FARO alert for May 8
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
